Sefam Medical Ltd’s Post

This study shows that people adhering to CPAP therapy for OSA exhibit healthier behaviors (e.g., better cardiovascular medication adherence, non-smoking) and lower healthcare resource use before commencing CPAP treatment. Adherence to CPAP was linked to these healthy behaviors. However, the study cautions that the "healthy adherer effect" needs further investigation before causal links can be established between CPAP adherence and improved health outcomes. Another interesting study here in Chest ⬇️ Congrats to the authors @Claire Launois Sébastien BAILLY AbdelKebir SABIL, PhD @François Goupil @Thierry Pigeanne @Carole Hervé @Philippe Masson @Acya Bizieux-Thaminy @Nicole Meslier Sandrine KERBRAT @Wojciech Trzepizur Pr Frédéric Gagnadoux Sefam Medical Ltd Sefam Sefam Medical South Europe SEFAM INDIA

Not distinguishing between central and obstructive hypopneas may lead to an underestimation of CSA severity, adversely affecting treatment decisions and limiting potential improvements in quality of life and sleepiness for appropriately treated patients with CSA. Important finding in this research here ⬇ Sefam Medical Ltd Sefam Sefam Medical South Europe SEFAM INDIA Michael McEwan Katie Simpson Kuldip Madar Anthony W. Allen Charlotte Gough AbdelKebir SABIL, Congratulations to all the authors Jean-louis pepin, Alan Schwartz Rami Khayat robin germany Scott McKane van Ngo Sébastien BAILLIEUL Sébastien BAILLY Renaud Tamisier Link to full paper also in comments

Sleep medicine clinicians - If you have not read this paper in the ERJ already it’s worth a read ⬇️ Sefam Medical UK Sefam Sefam Medical South Europe SEFAM INDIA Michael McEwan Katie Simpson Anthony W. Allen Kuldip Madar Liam Ions Charlotte Gough AbdelKebir SABIL, PhD

This study compared the effectiveness and safety of three medications used to treat excessive daytime sleepiness in people with obstructive sleep apnea. The study found that all three medications worked well, but one, pitolisant, had the best safety profile and overall benefit-risk ratio. The authors recommend more research with larger studies directly comparing these medications. Full text link here ⬇️ Sefam Medical UK Sefam SEFAM INDIA Sefam Medical South Europe Michael McEwan Katie Simpson Kuldip Madar Anthony W. Allen AbdelKebir SABIL, PhD #OSA #excessivedaytimesleepiness #alertingmedication

The Sefam S Box devices stand out with their innovative features designed to enhance patient care and streamline sleep apnoea management. Our cutting-edge software offers seamless connectivity, allowing users to effortlessly sync their data with multiple devices. This integration ensures accurate monitoring and provides healthcare professionals with real-time insights, making data-driven decision-making easier than ever. Our user-friendly interface and advanced analytics capabilities empower users to take control of their health journey. Sefam Medical UK Sefam SEFAM INDIA Sefam Medical South Europe Michael McEwan Katie Simpson Kuldip Madar Anthony W. Allen Liam Ions Charlotte Gough AbdelKebir SABIL, PhD Watch out for our new device the Nea coming soon to the UK Sleep medicine services. Check out the comments for a preview of the Nea #CPAP #SleepApnoea #Innovation #HealthTech #SefamSBox #SefamNea #ConnectedDevices

Another reason to consider using the Sunrise device in your sleep medicine service to screen for sleep apnoea. Dr Sulaiman S. Alsaif et al great work 👏👏👏 Sefam Medical UK Sunrise Visit our website where you can find out more about this innovative HSAT device https://lnkd.in/ePnRvC_x

Sefam Medical are the distributors of the Sunrise device in the UK. A small 3 g sensor that is placed on the chin during sleep screens for possible sleep apnoea. To find out more visit our website ⬇️ or watch the video link in the comments. https://lnkd.in/ePnRvC_x Sefam Medical UK Sunrise #osa #artificialintelligence #innovation #HSAT #sunrise

This study investigated the use MJM analysis with the Sunrise sensor during CPAP therapy to better understand air leaks. It highlighted that the amplitude of MJM coincides with peak air leak outflow during obstructive events, while arousals decrease air leak. The analysis suggests that examining air leaks with MJM can provide valuable insights into their origins and might open new avenues for CPAP management. Two case reports of patients with OSA using CPAP therapy, show how MJM analysis can distinguish between continuous and discontinuous air leaks, and how these leaks can be related to the level of respiratory effort and mouth opening. The study concludes that MJM analysis, in conjunction with air leak monitoring, can provide a more comprehensive assessment of CPAP therapy efficacy and help identify potential causes of leakages that can lead to decreased adherence and treatment outcomes. Read the full study here ⬇️ by Dr Martinot Jean-Benoît Atul Malhotra @dennis hwang @laurent hostaux @jean-louis pepin Sefam Medical UK Sefam SEFAM INDIA Sefam Medical South Europe Michael McEwan Kuldip Madar Katie Simpson Anthony W. Allen Liam Ions Charlotte Gough AbdelKebir SABIL, PhD Sunrise Fabien Crespo

Suggested read here for sleep medicine clinicians ⬇️ The PAP-RES algorithm is a new approach to CPAP therapy. The algorithm focuses on identifying OSA phenotypes, which are distinct groups of individuals with OSA who have different symptom burdens and cardiovascular vulnerability levels. This approach aims to personalize CPAP therapy based on the individual's phenotype, leading to better outcomes and a more effective treatment plan. Michael McEwan Katie Simpson Anthony Warren Kuldip Madar Liam Ions Charlotte Gough AbdelKebir SABIL, PhD Sefam Medical UK Sefam SEFAM INDIA Sefam Medical South Europe

Would recommend a read here ⬇️